Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Food Allergy
•
Primary Care
How do you counsel parents about the anticipated abdominal pain associated with oral desensitization in peanut-allergic children?
Related Questions
Do you reflexively test for tree nut allergies when you diagnose a peanut allergy?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
Based upon recently published information in the journal Science, would you offer zileuton to a high-risk food allergy patient who declines oral immunotherapy and omalizumab?
Are you initiating/discussing peanut OIT in most children less than age 2 due to the benefits of desensitization and remission?
How are you diagnosing chronic FPIES in adults?
Are your performing food challenges prior to starting OIT or omalizumab to determine if these patients have a threshold dose that would actually benefit from the intervention?
Is the timing of childhood eczema onset useful as a prognostic factor in predicting food allergy tolerance?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
Is there any way to perform a baked egg challenge in an infant, or best to wait until developmentally able to consume baked egg?
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
